Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models
- Ying Chen1,2,
- Yang Hu1,2,
- Mingkai Lin1,2,3,
- Alicia J. Jenkins2,4,
- Anthony C. Keech5,
- Robert Mott1,
- Timothy J. Lyons2 and
- Jian-xing Ma1,2⇓
- 1Department of Physiology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
- 2Harold Hamm Diabetes Center, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
- 3Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
- 4Department of Medicine, The University of Melbourne, Melbourne, Australia
- 5National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia
- Corresponding author: Jian-xing Ma, .
Y.C. and Y.H. contributed equally to this study.